Endotherapy Devices Market (2025-2032)

Endotherapy devices are inserted in the body during endoscopic procedures. Endotherapy devices such as needles, dilators, hemostasis systems, hemoclips, stents, and extraction systems are used during colonoscopies, gastroscopies, bronchoscopies, and other procedures. Endotherapy equipment is also used to diagnose abnormal growth in the colon and other abdominal organs and digestive tract hemorrhage. Additionally, they are employed therapeutically to eliminate tumors or polyps, halt bleeding, and widen strictures or confined bodily channels.

The growth of this market is driven by the increasing preference for minimally invasive procedures, the rising prevalence of gastrointestinal conditions, and technological advancements in endotherapy devices. However, the high cost of endoscopy procedures is restraining the market. The increasing demand for endoscopic procedures in emerging markets is creating opportunities for key players in the market. Additionally, the lack of skilled professionals is a major challenge for market growth.

Medical conditions such as abnormal growth in the gastrointestinal tract, abnormal bleeding in the digestive tract, inflammatory bowel disease (IBD), ulcerative colitis (UC), and chronic pancreatitis burden the healthcare system worldwide. According to the study published by American Gastroenterological Association in 2021, about 40% of the global population suffers from functional gastrointestinal disorders. Factors such as lifestyle changes, sedentary lifestyle, diet change, stress, and growing age contribute to the increasing prevalence of gastrointestinal disorders. Endotherapy devices are used in surgical procedures to examine or remove abnormal growth in the gastrointestinal or abdominal tract.

Endotherapy devices are used in the various endoscopic procedure employed in the treatment of gastrointestinal conditions, such as endoscopic retrograde cholangiopancreatography (ERCP), endoscopic submucosal dissection (ESD), and peroral endoscopic myotomy (POEM). Endotherapy devices are used to treat narrowed esophagus, abdominal pain, bleeding in the gastrointestinal tract, removal of foreign objects, and reduce the risk of infection.

The prevalence of gastrointestinal cancer is rising across the globe. According to WHO, gastrointestinal cancer accounts for one in four cases and one in three cancer deaths each year. Endotherapy devices play a major role in collecting tissue samples from different positions of the gastrointestinal tract for biopsy. Thus, rising incidences of gastrointestinal conditions and increasing adoption of endotherapy devices for various GI disorders drive market growth.

The market players are developing and launching new endotherapy devices to improve clinical outcomes. For instance, in April 2021, Argon Medical Devices, Inc. launched a Halo Single-Loop Snare Kits. The kits are used in the removal of foreign objects. Earlier, in June 2020, Cook Medical (U.S.) launched a transluminal Biliary Biopsy Forceps Set (BBFS) and a new 40-cm delivery system line extension of the existing Silver 635 biliary stent (ZIB). The forceps are used for accurate tissue samples for biopsy and ZIB stent is developed for treating biliary neoplasm.

Patients are increasingly preferring endoscopic procedures over traditional open surgeries. Unlike traditional surgeries, endoscopic procedures do not require large incisions on the body, thus reducing hospital stays and associated costs. Healthcare providers also opt for endoscopy as it involves less damage to patients’ bodies. The increasing adoption of endoscopic procedures for reduced post-surgery complications, rapid recovery, increased safety than traditional surgeries, minimal pain, and reduced in-hospital stay drives the preference for endoscopy procedures and the market growth.